Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(4-(4-(4-chloro-1-pyrazolyl)butyl)-1-piperazinyl)pyrimidine
2. E 4424
3. E-4424
4. E4424
5. Lesopitron
1. 132449-89-9
2. Lesopitron (dihydrochloride)
3. E-4424
4. 4t5l4t8473
5. 132449-89-9 (lesopitron Hcl)
6. Pyrimidine, 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)-, Dihydrochloride
7. 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)piperazin-1-yl)pyrimidine Dihydrochloride
8. Unii-4t5l4t8473
9. E 4424
10. 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)pyrimidine Dihydrochloride
11. Schembl1822413
12. Dtxsid00157588
13. Cs-6845
14. Lesopitron Dihydrochloride [mi]
15. Hy-101609
16. Q27260460
17. 2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine;dihydrochloride
18. Pyrimidine, 2-(4-(4-(4-chloro-1h-pyrazol-1-yl)butyl)-1-piperazinyl)-, Hydrochloride (1:2)
| Molecular Weight | 393.7 g/mol |
|---|---|
| Molecular Formula | C15H23Cl3N6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 392.104978 g/mol |
| Monoisotopic Mass | 392.104978 g/mol |
| Topological Polar Surface Area | 50.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 317 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A Lesopitron Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lesopitron Dihydrochloride, including repackagers and relabelers. The FDA regulates Lesopitron Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lesopitron Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lesopitron Dihydrochloride supplier is an individual or a company that provides Lesopitron Dihydrochloride active pharmaceutical ingredient (API) or Lesopitron Dihydrochloride finished formulations upon request. The Lesopitron Dihydrochloride suppliers may include Lesopitron Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Lesopitron Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lesopitron Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Lesopitron Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Lesopitron Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Lesopitron Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lesopitron Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Lesopitron Dihydrochloride USDMF includes data on Lesopitron Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lesopitron Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lesopitron Dihydrochloride suppliers with USDMF on PharmaCompass.
Lesopitron Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lesopitron Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lesopitron Dihydrochloride GMP manufacturer or Lesopitron Dihydrochloride GMP API supplier for your needs.
A Lesopitron Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Lesopitron Dihydrochloride's compliance with Lesopitron Dihydrochloride specifications and serves as a tool for batch-level quality control.
Lesopitron Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Lesopitron Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lesopitron Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Lesopitron Dihydrochloride EP), Lesopitron Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lesopitron Dihydrochloride USP).
LOOKING FOR A SUPPLIER?
